Moisture Milk Base

1. INCI et CAS

INCI: Glycerin · CAS: 56-81-5

2. Rôle dans la formule

Glycerin fills a polyol-humectant role in the listed cosmetic formats. Read its percentage as formulation guidance, not an assay.

3. Niveaux d'emploi typiques (repère de formulation)

• Gels and serums: 3–8%.
• 2–5% is listed for creams in this reference.
• For rinse-off, use 2–4%.

The guide places Glycerin in the water phase and calls for no melt step.

4. Sources réglementaires et conformité mondiale

• Treat any CosIng entry for Glycerin as a reference only; verify the grade and intended use under current market rules.
• Before EU placement, Regulation (EC) No 1223/2009 requires the final cosmetic with Glycerin to undergo a safety assessment as a finished-product assessment.
• Confirm the actual Glycerin grade from supplier documentation and check requirements where the product will be sold.

5. Sécurité et évaluation des risques

The guide records a level for cosmetic formulation purposes; this reference is not approval for drug use or OTC marketing and the final formula should undergo patch and stability assessment.

6. Stabilité et conditionnement

Protect sealed bulk from warmth and direct light; match the pack choice to the system's oxidation risk; use batch testing to verify stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• For cosmetic use, this entry records Glycerin in a direction centered on humectant function.

• The available ingredient details provides no basis for drug claims, cure claims, or a certification that is absent from the product records.
• This guide to Glycerin does not confirm whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

Squalane provides the referenced hydrocarbon-emollient role in a plant-derived grade; mineral oil is not part of this guide.

3. Niveaux d'emploi typiques (repère de formulation)

• For gel-creams, use 2–6% as a formulation guide.
• The guide range for dry oils is 10–30% in this reference.
• The stated reference for balms is 5–15%.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Sources réglementaires et conformité mondiale

• Database information on Squalane does not replace review of the supplied grade and finished product under market rules.
• For an EU-market product, Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Squalane is used as part of the finished cosmetic's safety documentation.
• Establish grade-specific details for Squalane from the supplier and assess filing requirements in the intended market.

5. Sécurité et évaluation des risques

The concentration shown is guidance for cosmetic formulation; the note establishes neither drug approval nor OTC-monograph status with patch response and finished-product stability still to be verified.

6. Stabilité et conditionnement

Use cool, sealed storage away from strong light for the bulk; evaluate packaging against the formula's susceptibility to oxidation; follow with stability and packaging checks on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• The development record cannot verify a drug effect, a clinical cure, or certification status not established for the SKU.
• The available details for Squalane is not evidence for whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI et CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Rôle dans la formule

Lotions, balms, and cleansing oils are the formats where this guide assigns caprylic/capric triglyceride a light-oil role.

3. Niveaux d'emploi typiques (repère de formulation)

• For lotions, use 3–8% in this reference.
• The formulation record indicates 20–60% for cleansing oils and balms as a formulation guide.

Route Caprylic/Capric Triglyceride through the oil phase.

4. Sources réglementaires et conformité mondiale

• CosIng information about Caprylic/Capric Triglyceride does not itself authorize a particular grade or finished cosmetic.
• The finished-product provisions of Regulation (EC) No 1223/2009 require an assessment addressing the safety of the finished product that contains Caprylic/Capric Triglyceride before the cosmetic is placed on the EU market.
• Verify the purchased Caprylic/Capric Triglyceride grade using supplier data, alongside the applicable filing rules for the destination market.

5. Sécurité et évaluation des risques

The use-level note is a reference for cosmetic formulation; it does not establish drug approval or OTC-monograph status while finished-product patch and stability testing remain necessary.

6. Stabilité et conditionnement

Keep the ingredient in cool, closed bulk storage away from sunlight; where oxidation is a concern, evaluate airless or pump packaging; check the finished formula and its packaging together.

7. Formulations d'allégations (à faire / à éviter)

• The formulation note describes Caprylic/Capric Triglyceride as part of a cosmetic direction focused on light-triglyceride.

• The development record does not support therapeutic effects, curative outcomes, or unsupported certification statements.
• The Caprylic/Capric Triglyceride entry cannot verify whitening, treatment of acne, perspiration control, sun protection, or hair growth.